Lifshitz Law Firm, P.C. Announces Investigation of Cellular Biomedicine Group, Inc. (NASDAQ: CBMG), GCI Liberty, Inc. (NASDAQ: GLIBA), Maxim Integrated Products (NASDAQ:MXIM), National General Holdings Corp. (NASDAQ: NGHC), Pfenex Inc. (NYSE: PFNX), Spring Bank Pharmaceuticals, Inc. (NASDAQ: SBPH), and Varian Medical Systems, Inc. (NYSE: VAR)

September 10, 2020 at 09:37 pm EDT

NEW YORK, Sept. 10, 2020 /PRNewswire/ --

Cellular Biomedicine Group, Inc. (NASDAQ: CBMG)

Lifshitz Law Firm, P.C. announces investigation into possible breach of fiduciary duties in connection with the sale of CBMG to members of CBMG management.

If you are a CBMG investor, and would like additional information about our investigation, please complete the Information Request Form.

GCI Liberty, Inc. (NASDAQ: GLIBA) - Liberty Broadband Corporation (NASDAQ GS: LBRDK)

Lifshitz Law Firm, P.C. announces investigation into possible breach of fiduciary duties in connection with the sale of GLIBA to Liberty Broadband Corporation (NASDAQ GS: LBRDK).

If you are a GLIBA or LBRDK investor, and would like additional information about our investigation, please complete the Information Request Form.

Jernigan Capital, Inc. (NYSE: JCAP)

Lifshitz Law Firm, P.C. announces investigation into possible breach of fiduciary duties in connection with the sale of JCAP to an affiliate of NexPoint Advisors, L.P. for $17.30 per share.

If you are a JCAP investor, and would like additional information about our investigation, please complete the Information Request Form.

Maxim Integrated Products (NASDAQ: MXIM) – Analog Devices (NASDAQ: ADI)

Lifshitz Law Firm, P.C. announces investigation into possible breach of fiduciary duties in connection with the proposed merger of MXIM and ADI.

If you are a MXIM or ADI investor, and would like additional information about our investigation, please complete the Information Request Form.

National General Holdings Corp. (NASDAQ: NGHC)

Lifshitz Law Firm, P.C. announces investigation into possible breach of fiduciary duties in connection with the sale of NGHC to Allstate Corporation for $32.00 in cash and closing dividends expected to be $2.50 per share.

If you are a NGHC investor, and would like additional information about our investigation, please complete the Information Request Form.

Otelco Inc. (NASDAQ: OTEL)

Lifshitz Law Firm, P.C. announces investigation into possible breach of fiduciary duties in connection with the sale of OTEL to of Oak Hill Capital for $11.75 per share.

If you are an OTEL investor, and would like additional information about our investigation, please complete the Information Request Form.

Pfenex Inc. (NYSE: PFNX)

Lifshitz Law Firm, P.C. announces investigation into possible breach of fiduciary duties in connection with the sale of PFNX to Ligand Pharmaceuticals Incorporated.

If you are a PFNX investor, and would like additional information about our investigation, please complete the Information Request Form.

Spring Bank Pharmaceuticals, Inc. (NASDAQ: SBPH)

Lifshitz Law Firm, P.C. announces investigation into possible breach of fiduciary duties in connection with the sale of SBPH to F-star Therapeutics, Limited.

If you are a SPBH investor, and would like additional information about our investigation, please complete the Information Request Form.

Varian Medical Systems, Inc. (NYSE: VAR)

Lifshitz Law Firm, P.C. announces investigation into possible breach of fiduciary duties in connection with the sale of VAR to Siemens Healthineers AG for $177.50 per share.

If you are a VAR investor, and would like additional information about our investigation, please complete the Information Request Form or contact Joshua Lifshitz, Esq. by telephone at (516)493-9780 or e-mail at info@jlclasslaw.com.

ATTORNEY ADVERTISING.© 2020 Lifshitz Law Firm, P.C. The law firm responsible for this advertisement is Lifshitz Law Firm, P.C., 821 Franklin Avenue, Suite 209, Garden City, New York 11530, Tel: (516)493-9780. Prior results do not guarantee or predict a similar outcome with respect to any future matter.

Contact:

Joshua M. Lifshitz, Esq.
Lifshitz Law Firm, P.C.
Phone: 516-493-9780
Facsimile: 516-280-7376
Email: info@jlclasslaw.com

View original content:http://www.prnewswire.com/news-releases/lifshitz-law-firm-pc-announces-investigation-of-cellular-biomedicine-group-inc-nasdaq-cbmg-gci-liberty-inc-nasdaq-gliba-maxim-integrated-products-nasdaqmxim-national-general-holdings-corp-nasdaq-nghc-pfenex-301128093.html

SOURCE Lifshitz & Miller Law Firm

Jernigan Capital, Inc. announced that it has received $43.223385 million in funding	Dec. 14	CI
Jernigan Capital, Inc. announced that it expects to receive $43.223385 million in funding	Dec. 07	CI
Nexpoint Storage Partners, Inc. announced a financing transaction	23-03-19	CI
Nexpoint Storage Partners, Inc. acquired 29 Self Storage Properties from SAFStor, Inc.	22-12-11	CI
Jernigan Capital, Inc. announced a financing transaction	22-12-07	CI
NexPoint Launches NexPoint Storage Partners as a Dedicated Platform for the Self-Storage Sector	20-12-08	CI
Nexpoint Storage Partners, Inc. announced that it has received $0.125 million in funding	20-11-30	CI
Nexpoint Storage Partners, Inc. announced that it expects to receive $0.125 million in funding	20-11-29	CI
Jernigan Capital, Inc. Reports Earnings Results for the Third Quarter Ended September 30, 2020	20-11-09	CI
Jernigan Capital, Inc. announced that it has received $300 million in funding from Extra Space Storage Inc.	20-11-08	CI
Jernigan Capital, Inc. Announces in Connection with the Mergers, All Members of the Board of Directors Ceased to Serve in Such Capacity	20-11-06	CI
Nexpoint Advisors, L.P. completed the acquisition of Jernigan Capital, Inc..	20-11-05	CI
Jernigan Capital, Inc. announced that it expects to receive $300 million in funding from Extra Space Storage Inc.	20-11-05	CI
Jernigan Capital, Inc.'s Equity Buyback announced on May 23, 2016, has expired.	20-11-05	CI
Jernigan Capital, Inc.(NYSE:JCAP) dropped from S&P TMI Index	20-11-03	CI
Jernigan Capital, Inc.(NYSE:JCAP) dropped from S&P Global BMI Index	20-11-03	CI
Tranche Update on Jernigan Capital, Inc.'s Equity Buyback Plan announced on May 23, 2016.	20-08-10	CI
Jernigan Capital, Inc. Reports Earnings Results for the Second Quarter Ended June 30, 2020	20-08-06	CI
Nexpoint Advisors, L.P. made a non-binding letter of intent to acquire Jernigan Capital, Inc. for approximately $400 million.	20-08-02	CI
Jernigan Capital, Inc.(NYSE:JCAP) added to Russell 2000 Dynamic Index	20-06-29	CI
Jernigan Capital, Inc.(NYSE:JCAP) added to Russell 2000 Dynamic Index	20-06-26	CI
Tranche Update on Jernigan Capital, Inc.'s Equity Buyback Plan announced on May 23, 2016.	20-05-08	CI
Transcript : Jernigan Capital, Inc., Q1 2020 Earnings Call, May 08, 2020	20-05-08
Jernigan Capital, Inc. Suspends Earnings Per Share Guidance for Full Year 2020; Announces Impairment of Goodwill for the Three Months Ended March 31, 2020	20-05-07	CI
Jernigan Capital, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2020	20-05-07	CI

Jernigan Capital, Inc.

Equities

JCAP

US4764051052

Latest news about Jernigan Capital, Inc.

Chart Jernigan Capital, Inc.

Company Profile